Globotriaosylceramide (non-hydroxy) (porcine RBC) 

Globotriaosylceramide (non-hydroxy) (porcine RBC) is a glycosphingolipid found in the cell membranes of mammals. Globotriaosylceramide (non-hydroxy) (porcine RBC) is the core pathogenic molecule of Fabry disease, and its level can be downregulated by supplementing α-galactosidase A. Globotriaosylceramide (non-hydroxy) (porcine RBC) amplifies B-cell receptor signals by regulating the localization of co-receptor CD19, and can be used as a vaccine adjuvant, capable of guiding the generation of broad-spectrum and cross-protective antibody responses. Globotriaosylceramide (non-hydroxy) (porcine RBC) promotes wound healing and reduces scar formation by regulating fibroblast heterogeneity^[1][2][3].

812.92

C₃₇H₆₆NO₁₈

O[C@H]1[C@@H]([C@H](O[C@H]([C@@H]1O)OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC([R])=O)CO)O[C@@]2(O[C@@H]([C@@H]([C@@H]([C@H]2O)O)O[C@@]3([C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)[H])CO)[H]

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Feldt-Rasmussen U, et al. Fabry disease: a new challenge in endocrinology and metabolism? Eur J Endocrinol. 2002 Jun;146(6):741-2.  [Content Brief]

  [2]. Sharma P, et al. The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity. Science. 2024 Feb 16;383(6684):eadg0564.

  [3]. Xie S, et al. Globotriaosylceramide Gb3 Influences Wound Healing and Scar Formation by Orchestrating Fibroblast Heterogeneity. Adv Sci (Weinh). 2025 Nov;12(41):e09733.  [Content Brief]